Cancer Research Targets Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oster, H.
Right arrow Articles by Leitges, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oster, H.
Right arrow Articles by Leitges, M.
[Cancer Research 66, 6955-6963, July 15, 2006]
© 2006 American Association for Cancer Research

Molecular Biology, Pathobiology, and Genetics

Protein Kinase C {alpha} but not PKC{zeta} Suppresses Intestinal Tumor Formation in ApcMin/+ Mice

Henrik Oster1 and Michael Leitges1,2

1 Laboratory for Signal Transduction, Max Planck Institute of Experimental Endocrinology and 2 Department of Nephrology, Hannover Medical School, Hannover, Germany

Requests for reprints: Michael Leitges, Department of Internal Medicine/Nephrology, Hannover Medical School, Carl Neuberg Strasse Nr. 1, Hannover, Germany 30625. Phone: 49-511-5359-127; Fax: 49-511-5359-186; E-mail: michael.leitges{at}mpihan.mpg.de.

Members of the protein kinase C (PKC) family of serine/threonine kinases play key regulatory roles in numerous cellular processes, including differentiation and proliferation. Of the 11 mammalian PKC isoforms known, several have been implicated in tumor development and progression. However, in most cases, isotype specificity is poorly defined, and even contrary functions for a single PKC have been reported mostly because appropriate molecular and genetic tools were missing to specifically assess the contribution of single PKC isoforms in vivo. In this report, we therefore used PKC genetic targeting to study the role of PKC{alpha} and PKC{zeta} in colorectal cancer. Both isoforms were found to be strongly down-regulated in intestinal tumors of ApcMin/+ mice. A deletion of PKC{zeta} did not affect tumorigenesis in this animal model. In contrast, PKC{alpha}-deficient ApcMin/+ mice developed more aggressive tumors and died significantly earlier than their PKC{alpha}-proficient littermates. Even without an additional Apc mutation, PKC{alpha} knockout mice showed an elevated tendency to develop spontaneous intestinal tumors. Transcriptional profiling revealed a role for this kinase in regulating epidermal growth factor receptor (EGFR) signaling and proposed a synergistic mechanism for EGFR/activator protein and WNT/APC pathways in mediating intestinal tumor development. (Cancer Res 2006; 66(14): 6955-63)




This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
S. Dupasquier, R. Abdel-Samad, R. I. Glazer, P. Bastide, P. Jay, D. Joubert, V. Cavailles, P. Blache, and C. Quittau-Prevostel
A new mechanism of SOX9 action to regulate PKC{alpha} expression in the intestine epithelium
J. Cell Sci., July 1, 2009; 122(13): 2191 - 2196.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. R. Murray, J. Weems, U. Braun, M. Leitges, and A. P. Fields
Protein Kinase C {beta}II and PKC{iota}/{lambda}: Collaborating Partners in Colon Cancer Promotion and Progression
Cancer Res., January 15, 2009; 69(2): 656 - 662.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka
Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester
Cancer Res., January 1, 2008; 68(1): 64 - 72.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. J. Lee, Y. Ji, S. Paul, H. Maehr, M. Uskokovic, and N. Suh
Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D3 Analogue Is Mediated by Ras/Protein Kinase C{alpha}
Cancer Res., December 15, 2007; 67(24): 11840 - 11847.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Fevr, S. Robine, D. Louvard, and J. Huelsken
Wnt/{beta}-Catenin Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells
Mol. Cell. Biol., November 1, 2007; 27(21): 7551 - 7559.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A. Gregorieff and H. Clevers
Giving APCmin tumours a SPARC
Gut, October 1, 2007; 56(10): 1341 - 1343.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Guan, K. Song, M. A. Pysz, K. J. Curry, A. A. Hizli, D. Danielpour, A. R. Black, and J. D. Black
Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells
J. Biol. Chem., May 11, 2007; 282(19): 14213 - 14225.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.